2007 news archive
Cambridge, U.K. – 12th December 2007
Amura receives grant of WO04007501 in China
Amura announced its WO04007501 has been granted in China (No. ZL 03821925.5). This provides further territorial protection to Amura’s AMcore™ intellectual property portfolio.
Cambridge, U.K. – 22nd November 2007
Amura announces single-crystal XRD confirmation for key AMcore™ intermediate in its osteoporosis programme
Read full press release here
Cambridge, U.K. – 18th September 2007
Amura announces positive results for its osteoporosis programme
Read full press release here
Cambridge, U.K. – 10th September 2007
Amura receives grant of WO02057270 in the Ukraine
Amura announced its WO02057270 has been granted in the Ukraine (No. 80250). This provides further territorial protection to Amura’s AMcore™ intellectual property portfolio.
Cambridge, U.K. – 9th August 2007
Amura receives grant of WO0232423 in Australia
Amura announced its WO0232423 has been granted in Australia (No. 2001094004). This provides further territorial protection to Amura’s b-lactamase intellectual property portfolio
Cambridge, U.K. – 26th July 2007
Amura announces positive results in a human breast cancer model of bone metastasis
Read full press release here
Cambridge, U.K. – 24th July 2007
Amura receives grant of WO02057270 in Mexico
Amura announced its WO02057270 has been granted in Mexico (No. 247475). This provides further territorial protection to Amura’s AMcore™ intellectual property portfolio.
Cambridge, U.K. – 24th July 2007
Amura receives grant of WO0232423 in United States
Amura announced its WO0232423 has been granted in the United States (No. 7247622). This provides further territorial protection to Amura’s b-lactamase intellectual property portfolio.
Cambridge, U.K. – 20th July 2007
Amura announces granting of a key ß-lactamase inhibitor patent by the United States Patent and Trademark Office
Read full press release here
Cambridge, U.K. – 10th July 2007
Amura announces descision to grant of a key ß-lactamase inhibitor patent (WO02032423/EP01974489.5) by the European Patent Office
Cambridge, U.K. – 14th June 2007
Amura receives grant of WO0232423 in Mexico
Amura announced its WO0232423 has been granted in Mexico (No. 246442). This provides further territorial protection to Amura’s b-lactamase intellectual property portfolio.
Cambridge, U.K. – 17th May 2007
Amura receives 'Notice of Allowance' from the US examiner for a key ß-lactamase inhibitor patent thereby initiating the granting procedure
Read full press release here
Cambridge, U.K. – 03rd May 2007
Amura announces that its lead compounds for osteoporosis and bone metastasis have demonstrated good in vivo safety profiles in repeat-dose toxicity study
Read full press release here
Cambridge, U.K. – 21st February 2007
Amura announces the assignment of the rights to the ProtoDiscovery™ computational technology platform and in silico screening/design business to Prosarix Ltd
Read full press release here
|
.jpg)
